Author: Yuanmei Zhu; Danwei Yu; Hongxia Yan; Huihui Chong; Yuxian He
Title: Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity Document date: 2020_3_28
ID: cogk5kig_4
Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.26.009233 doi: bioRxiv preprint 6 results demonstrated that overexpression of ACE2 can promote the cell entry of both the 99 SARS-CoV-2 and SARS-CoV pseudoviruses as well as the S protein-mediated cell-cell 100 fusion activity, verifying the functionality of ACE2 for SARS-CoV-2......
Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.26.009233 doi: bioRxiv preprint 6 results demonstrated that overexpression of ACE2 can promote the cell entry of both the 99 SARS-CoV-2 and SARS-CoV pseudoviruses as well as the S protein-mediated cell-cell 100 fusion activity, verifying the functionality of ACE2 for SARS-CoV-2.
Search related documents:
Co phrase search for related documents- cell cell and SARS CoV SARS: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- cell entry and protein mediate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- cell entry and SARS CoV SARS: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77
- protein mediate and SARS CoV SARS: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date